X-ELIO, a global leader in renewable energy, has signed a multi-buyer Power Purchase Agreement (PPA) with an Energize program ...

Harvey Jones isn't having much fun playing the GSK share price game. The FTSE 100 pharmaceutical stock must work hard to make ...

Thermo Fisher Scientific Inc. , the world leader in serving science, today announced a 10-year virtual power purchasing agreement (VPPA) with international renewable energy developer X-ELIO designed ...

The execs at Haleon, a huge multinational consumer products company, ought to take a good look in the mirror. That is, unless misleading, sleazy marketing is in their mission statement. In that case, ...

The Motley Fool UK has recommended GSK and Haleon Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations ...

Consumer health care company Haleon plans to invest $54.2 million to upgrade its research and development facility in Richmond’s Northside.

In its first set of quarterly results since it separated from its consumer health business, GSK has exceeded analysts ... pure-play since the spin-off of Haleon in July – also raised its ...

GSK, its consumer health spin-off Haleon, and Sanofi could be on the hook for billions of dollars in potential damages over Zantac, a gastrointestinal drug pulled from the market in 2020 after it ...